Colgate-Palmolive (NYSE:CL) Shares Acquired by Bridgewater Advisors Inc.

Bridgewater Advisors Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,990 shares of the company’s stock after buying an additional 1,382 shares during the quarter. Bridgewater Advisors Inc.’s holdings in Colgate-Palmolive were worth $4,996,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at $53,000. Prospera Private Wealth LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at $64,000. True Wealth Design LLC boosted its position in shares of Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its holdings in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the subject of several research analyst reports. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, UBS Group cut their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Stock Up 0.3 %

Shares of CL opened at $88.79 on Monday. The business’s 50 day simple moving average is $92.20 and its 200-day simple moving average is $97.75. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.